New GLP
Updated 2025 GLP-1 guidelines for type 2 diabetes , including clinical insights, prescribing tips, and what healthcare providers need to know.
The American Diabetes Association (ADA) recently released their 2025 Standards of Care, which - for the first time - includes recommendations for CGM use in type 2 diabetes , the use of GLP-1 drugs for kidney and heart health, and more.
Diabetes Standards of Care (2025)
The guidelines have been updated to recommend the use of either SGLT2 inhibitor or GLP-1 RA for individuals with type 2 diabetes and CKD, based on proven benefits.
The ADA Guidelines 2025 reaffirm metformin as the first-line therapy for Type 2 diabetes unless contraindicated. However, the guidelines give increasing prominence to GLP-1 receptor agonists and SGLT2 inhibitors for patients with cardiovascular or kidney disease, even at early stages of diabetes .
ADA Updates Diabetes Treatment Guidelines to Reflect Benefits of GLP
The American Diabetes Association updated the pharmacological glycemic treatment of their "Standards of Care in Diabetes 2025 " to better reflect the use of glucagon-like peptide-1 ( GLP-1 ) medication and treatment of concurrent conditions, such as weight, cardiovascular, and kidney issues. 1
The field of diabetes care is rapidly changing as new research, technology, and treatments that can improve the health and well-being of people with diabetes continue to emerge. With annual updates since 1989, the American Diabetes Association has long been a leader in producing guidelines that capture the most current state of the field.
Your Guide to the 2025 ADA Standards of Care
The American Diabetes Association (ADA) recently released their 2025 Standards of Care, which - for the first time - includes recommendations for CGM use in type 2 diabetes , the use of GLP-1 drugs for kidney and heart health, and more.
Today, the American Diabetes Association® released the Standards of Care in Diabetes—2025 (Standards of Care) the gold standard in evidence-based guidelines for diagnosing and managing diabetes and prediabetes.
Changes to the Standards of Care in Diabetes2025
The American Diabetes Association's (ADA) Standards of Care in Diabetes informs health care professionals about the latest evidence for diagnosing and managing diabetes . The 2025 Standards of Care includes updates to nearly all sections, including revised recommendations for diabetes medications type 1 diabetes testing evidence-based eating patterns The updated Standards of Care also ...
Glycemic monitoring with CGMs, glucose-lowering agents ( GLP-1 receptor agonists), innovative insulin delivery systems, and mental health check- ins are just a few updates to the ADA 2025 Standards of Care.